TY  - CONF

T1  - Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years With Moderate-to- Severe Atopic Dermatitis Treated With Dupilumab in an Open-Label Extension Clinical Trial

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2023/01/01

AU  - Paller A

AU  - Siegfried E

AU  - Sidbury R

AU  - Lockshin B

AU  - Cork M

AU  - Pinter A

AU  - Xiao J

AU  - Stanton S

AU  - Khokhar F

AU  - Bansal A

AU  - Prescilla R

ED  - 

VL  - 89

IS  - 3

SP  - AB100

EP  - AB100

Y2  - 2024/12/22

ER  -